• Density：
  1.306 g/cm3

Huateng Pharmaceutical, a global supplier of pharmaceutical intermediates & chemical products & biological reagent & PEG derivatives, offers Ixazomib, CAS NO.1072833-77-2 for your requirements of R&D, evaluation, pilots and commercial along with supportive technical package required for evaluation.

Application: Ixazomib is a proteasome inhibitor that acts by preventing cell growth in solid tumours. It is an anticancer agent that is used to treat patients with multiple myeloma and is potentially neurotoxic.

Find More Ixazomib Intermediates>>>